Website
Chinese Journal of Oncology Prevention and Treatment ›› 2025, Vol. 17 ›› Issue (1): 1-10.doi: 10.3969/j.issn.1674-5671.2025.01.01
Online:2025-02-25
Published:2025-03-06
CLC Number:
Tumor marker committee of China Anti-Cancer Association, Integrative Oncology Branch of the China Anti-Cancer Association. China expert consensus on diagnosis and treatment of lymphoepithelial carcinoma (2025 edition)[J].Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 1-10.
| [1] | SHAN Tiyan, LYU Sihui, CHEN Xi, LIANG Jinlan, YAN Bingxiong, SONG Zhijun, WANG Qi. Isolation,identification and anti-ovarian cancer activity of sophoranochromene and sophoradin [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 156-163. |
| [2] | LU Jianling, WEI Chunhua, ZHOU Zihan, CAO Ji, LI Qiulin, TANG Xiaozhun, YU Hongping. Epidemic characteristics of thyroid cancer in Guangxi cancer registration areas in 2019 and trends analysis from 2012 to 2019 [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 133-138. |
| [3] | LYU Ruibo, AN Sanchun, LI Yunxi, ZHANG Chaojun, QIU Jie, CHEN Xiaomei, LUO Yunbo, DENG Wei, HUANG Tianren. Screening and follow-up results of the early diagnosis and treatment program for liver cancer: a data analysis based on Fusui County, Guangxi, 2011—2020 [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 139-144. |
| [4] | LIANG Xiumei, CHEN Weiyi, ZHOU Zihan, MA Liang, WU Yun, LU Xiangning, XIANG Bangde, YU Hongping, LYU Hanbin. Analysis of survival characteristics in liver cancer inpatients: a 10-year follow-up cohort from a cancer hospital in Guangxi (2010—2020) [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 145-149. |
| [5] | DU Yi, YUE Jing, CHEN Jingyao, ZHOU Shengtao. Cultivation and gene editing of mouse oviductal epithelial organoids [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 150-156. |
| [6] | SUN Jiamin , ZHANG Shiyi, LIAO Xiwen, ZHONG Jianhong, WANG Qiuyan , TAO Yuting. Mechanism and clinical significance of collagen crosslinking-mediated extracellular matrix remodeling in hepatocellular carcinoma dedifferentiation [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 164-171. |
| [7] | MENG Jing, ZHANG Dongdong, HAN Xi, QU Xueying, SONG Hanjun, ZHANG Pengxia. FAM50A gene knockdown suppresses malignant biological behaviors of colorectal cancer cells via the Caspase-3/PARP-mediated apoptotic signaling [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 172-180. |
| [8] | LI Yongfeng, WAN Fengjie, WEN Sha, YANG Lichao, OU Meizhen, LIAO Zhouxiang, WU . FAM50A gene knockdown suppresses malignant biological behaviors of colorectal cancer cells via the Caspase-3/PARP-mediated apoptotic signaling [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 180-187. |
| [9] | LIANG Huiting, BI Shiwen, LIU Ben, LU Tingting, WANG Qi, SHI Lijun. Alterations of HSP90AB1 expression in ovarian cancer during cisplatin resistance and its clinical significance [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 188-195. |
| [10] | WANG Shenghui, ZHANG Zongnai , JIA Zhichao, ZHENG Bin, LI Xiaoyu , GAO Yuan , ZHOU Mai. CRS combined with HIPEC for peritoneal metastasis in colorectal cancer: correlation between primary tumor location and clinical outcomes [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 195-200. |
| [11] | ZHAO Min, ZHANG Maoxiang, SUN Huixin, WANG Wanying, JIA Haihan, SONG Bingbing. Survey on awareness rate of core knowledge of cancer prevention and treatment and its influencing factors: a population-based data analysis in Heilongjiang Province,China [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 201-206. |
| [12] | SUN Ting, LIU Jiahuan, CAI Lina, ZHENG Hengyu, YE Xianghong. Best evidence of preoperative nutritional intervention in neoadjuvant chemotherapy for gastric cancer patients [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 207-. |
| [13] | ZHONG Limei, JIN Feng. Advance in treatment of recurrent/metastatic nasopharyngeal carcinoma [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 215-222. |
| [14] | TIAN Shengyu, LU Weixiang, LIANG Xiaojie, WANG Liang. Advances in universal CAR-T cell therapy for hematologic malignancies: strategies to overcome GvHD/HvG [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 223-229. |
| [15] | WU Xinyu , DAI Hanjue , JIANG Hua. Exploring the mechanisms of gastric cancer development and therapeutic strategies from an evolutionary perspective [J]. Chinese Journal of Oncology Prevention and Treatment, 133, 17(2): 230-236. |
|
||
